Entecavir vs Lamivudine for Prevention of Hepatitis B Virus Reactivation Among Patients With Untreated Diffuse Large B-Cell Lymphoma Receiving R-CHOP Chemotherapy-Reference-Cited by-同舟云学术

Entecavir vs Lamivudine for Prevention of Hepatitis B Virus Reactivation Among Patients With Untreated Diffuse Large B-Cell Lymphoma Receiving R-CHOP Chemotherapy

Published:2014-12-17 Issue:23 Volume:312 Page:2521
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Huang He¹,Li Xueying¹,Zhu Jun²,Ye Sheng³,Zhang Hongyu⁴,Wang Wei⁵,Wu Xiangyuan⁶,Peng Jiewen⁷,Xu Bing⁸,Lin Yingcheng⁹,Cao Yabing¹⁰,Li Haoran¹,Lin Suxia¹¹,Liu Qing¹²,Lin Tongyu¹

Affiliation:

1. Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China

2. Department of Medical Oncology, Beijing Cancer Hospital, Beijing, China

3. Department of Medical Oncology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

4. Department of Medical Oncology, Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China

5. Cancer Center of the First People’s Hospital of Foshan, Foshan, China

6. Department of Medical Oncology, Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

7. Cancer Center of People’s Hospital of Zhongshan, Zhongshan, China

8. Department of Hematology, Southern Hospital of Southern Medical University, Guangzhou, China

9. Department of Medical Oncology, Cancer Hospital, Shantou University Medical College, Shantou, China

10. Cancer Center of Kiang Wu Hospital, Macau, China

11. Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China

12. Department of Epidemiology and Biostatistics, Sun Yat-sen University Cancer Center, Guangzhou, China

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 196 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of infections for patient treated with ibrutinib in clinical practice;Frontiers in Oncology;2024-09-10

2. Hepatitis B virus reactivation risk associated with immune checkpoint inhibitors in tumor treatment: a retrospective study;Japanese Journal of Clinical Oncology;2024-08-24

3. CAR-T therapy demonstrated safety and efficacy in relapsed/refractory diffuse large B-cell lymphoma patients complicated with hepatitis B related cirrhosis;2024-08-10

4. Hepatitis B Virus Reactivation in Cancer Patients Receiving Chemotherapy—A Systematic Review and Meta-Analysis;Seminars in Oncology;2024-08

5. Successful Treatment of Hepatitis B Virus Reactivation With a Combination of Entecavir and Short-Term Administration of Interferon-β Twice per Day;Cureus;2024-07-06